期刊文献+

在哺乳动物细胞中稳定表达丙型肝炎病毒E2糖蛋白 被引量:4

Stable Expression of E2 Glycoprotein of Hepatitis C Virus in Mammalian Cell
下载PDF
导出
摘要 利用DNA重组技术,将Ⅲ型中国株HCVE2/NS1基因片段插入真核表达载体,然后转染哺乳动物细胞NIH3T3以表达E2糖蛋白.检测显示来自3月以上培养的细胞克隆中表达产物分子量为70kD,经Westernblot证实该表达产物能与抗HCV阳性血清进行特异性反应.以上表明首次在哺乳动物细胞中成功表达Ⅲ型中国株HCV的E2糖蛋白,并建立相应的稳定表达细胞系. E2/NS1 gene derived from a Chinese genotype Ⅲ isolate of hepatitis C virus was amplified by reverse transcription polymerase chain reaction method and inserted into mammalian expression vector pcDNA3 for E2 glycoprotein expression.The recombinant plasmid p3W14 containing nearly full length E2/NS1 gene downstream of CMV promoter and upstream of BGH polyA was transfected into mammalian cell NIH3T3 by calcium phosphate method.Cells were selected by G418.The G418 resistant clonal cells were cultured more than three months.Cell lysates were analyzed by SDS PAGE and Western Blot.The results showed that the new protein from the mammalian cell was 70 kD,reacting specifically to anti HCV sera,and proved to be E2 glycoprotein of hepatitis C virus.E2/NS1 gene also could be detected in the genomic DNA from neomycin resistance cells by PCR amplification.Additionally,the expression level of E2 glycoprotein had no significant change compared with that of three months before.It was the first time for successfully expression E2 glycoprotein derived from a Chinese HCV isolate lonely and establishment of cell lines for stable expression.
出处 《中国生物化学与分子生物学报》 CAS CSCD 1998年第1期15-15,共1页 Chinese Journal of Biochemistry and Molecular Biology
基金 九五攻关项目
关键词 丙型肝炎病毒 包膜蛋白 稳定表达 哺乳动物 Hepatitis C virus,Envelope protein,Stable expression
  • 相关文献

参考文献1

  • 1Lin C,J Virol,1994年,68卷,5063页

同被引文献13

  • 1Choo Q L, Weiner L K, Overby L R, et al. Isolation of a cDNA clone derived from a blood-borne Non2A,Non2B viral hepatitis genome[J].Science, 1989,244:359-366.
  • 2Chargelegue D,Obregon P, Drake P M. Transgenic plants for vaccine production: expectations and limitations[J].Trends in Plant Science, 2001,6:495-496.
  • 3Streatfield S J ,Jilka J M, Hood E E, et al. Plant-based vaccines: unique advantages[J].Vaccine, 2001,19:2742-2748.
  • 4Cohen J. The scientific challenge of hepatitis C[J]. Science ,1999,285(5424) :26-30.
  • 5Lechmann M, Liang T J. Vaccine development for hepatitis C[J]. Semin Liver Dis ,2000,20(2) :211-226.
  • 6Makela P H. Vaccines,coming of age after 200 years [J ]. FEMS Microbiology Review,2000,24:9-20.
  • 7Yurkova M S, Patel A H, Fedorov A N. Characterisation of bacterially expressed structural protein E2 of hepatitis C virus[J]. Protein Expression and Purification ,2004,37( 1 ) : 119-125.
  • 8萨姆布鲁克J 拉塞尔DW.黄培堂 王嘉玺 朱厚础 等译.分子克隆实验指南第3版[M].北京:科学出版社,2002.1713-1712,1723-1726.
  • 9王晓洁,谭文杰,丛旭,郭可謇.丙型肝炎病毒结构蛋白在痘苗病毒中的表达[J].中华实验和临床病毒学杂志,1997,11(4):340-343. 被引量:3
  • 10谢尧,陶其敏.基因免疫中HBV preS对HCV E2蛋白免疫原性的调控[J].中华微生物学和免疫学杂志,1999,19(3):222-223. 被引量:2

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部